Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men

被引:67
作者
Christmas, C
O'Connor, KG
Harman, SM
Tobin, JD
Münzer, T
Bellantoni, MF
Clair, CS
Pabst, KM
Sorkin, JD
Blackman, MR
机构
[1] NIA, Endocrine Sect, Clin Invest Lab, Intramural Res Program,NIH, Bethesda, MD 20892 USA
[2] NIA, Appl Physiol Sect, Clin Invest Lab, Intramural Res Program,NIH, Bethesda, MD 20892 USA
[3] NIA, Metab Sect, Clin Invest Lab, Intramural Res Program,NIH, Bethesda, MD 20892 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA
[6] NIA, Lab Clin Invest, Natl Ctr Complementary & Alternat Med, Endocrine Sect,Intramural Res Program,NIH, Bethesda, MD 20892 USA
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2002年 / 57卷 / 01期
关键词
D O I
10.1093/gerona/57.1.M12
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. Aging is associated with concomitant declines in activity of the growth hormone (GH) and gonadal steroid axes, and in bone mineral density (BMD). in both sexes. Long-term estrogen replacement slows bone loss and prevents fractures in postmenopausal women, whereas the effects of supplementation of GH or testosterone on bone metabolism and BMD in aged individuals remains uncertain. Methods. Using a randomized, placebo-controlled, double-blind study design, we investigated the separate and interactive effects of 6 months of administration of recombinant human GH and/or gonadal steroids on bone biochemical markers and BMD in 125 healthy, older (>65 years) women (n = 53) and men (n = 72) with age-related reductions in GH and gonadal steroids. Results. In women. administration of GH. but not GH + hormone replacement therapy (HRT). increased serum levels of osteocalcin and procollagen peptide (PICP) and increased urinary excretion of deoxypyridinoline (DPD) crosslinks. Urinary calcium excretion decreased after HRT. In men. GH, and to a greater extent GH + T. increased osteocalcin. GH increased serum PICP. and GH + T increased urinary DPD. Urinary calcium excretion was unaffected by hormone treatment in men. In women. administration of HRT and GH + HRT, but not GH. increased BMD at the lumbar spine. femoral neck. and distal radius. In men, GH + T led to a small decrease in BMD at the proximal radius: there were no other significant effects of hormone administration on BMD. Conclusions. These data suggest that short-term administration of HRT exerts beneficial effects on bone metabolism and BMD in post menopausal women, which are not significantly altered by the coadministration of GH. In andropausal men, T administration to achieve physiologic levels did not result in significant effects on bone metabolism or BMD, whereas GH + T increased one marker of bone formation and decreased one marker of bone resorption. Given the known biphasic actions of GH on bone and the apparent favorable biochemical effects of GH + T in men. the longer-term effects of GH + T on BMD in aged men remain to be clarified.
引用
收藏
页码:M12 / M18
页数:7
相关论文
共 56 条
[1]  
ABBASI AA, 1995, AM J MED SCI, V310, P229
[2]   EFFECT OF TESTOSTERONE ON BONE-DENSITY AND BONE METABOLISM IN ADOLESCENT MALE HYPOGONADISM [J].
ARISAKA, O ;
ARISAKA, M ;
NAKAYAMA, Y ;
FUJIWARA, S ;
YABUTA, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (04) :419-423
[3]   EFFECT OF TESTOSTERONE ON RADIAL BONE-MINERAL DENSITY IN ADOLESCENT MALE HYPOGONADISM [J].
ARISAKA, O ;
ARISAKA, M ;
HOSAKA, A ;
SHIMURA, A ;
YABUTA, K .
ACTA PAEDIATRICA SCANDINAVICA, 1991, 80 (03) :378-380
[4]   Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency - A randomized, placebo-controlled trial [J].
Baum, HBA ;
Biller, BMK ;
Finkelstein, JS ;
Cannistraro, KB ;
Oppenheim, DS ;
Schoenfeld, AD ;
Michel, TH ;
Wittink, H ;
Klibanski, A .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (11) :883-+
[5]   Long-term effect of testosterone therapy on bone mineral density in hypogonadal men [J].
Behre, HM ;
Kliesch, S ;
Leifke, E ;
Link, TM ;
Nieschlag, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2386-2390
[6]   Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: A clinical research center study [J].
Bellantoni, MF ;
Vittone, J ;
Campfield, AT ;
Bass, KM ;
Harman, SM ;
Blackman, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :2848-2853
[7]   EFFECTS OF PROGESTIN-OPPOSED TRANSDERMAL ESTROGEN ADMINISTRATION ON GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I IN POSTMENOPAUSAL WOMEN OF DIFFERENT AGES [J].
BELLANTONI, MF ;
HARMAN, SM ;
CHO, DE ;
BLACKMAN, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (01) :172-178
[8]   Effects of hormone therapy on bone mineral density - Results from the postmenopausal estrogen/progestin interventions (PEPI) trial [J].
Bush, TL ;
Wells, HB ;
James, MK ;
BarrettConnor, E ;
Marcus, R ;
Greendale, G ;
Hunsberger, S ;
McGowan, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17) :1389-1396
[9]   Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review [J].
Carroll, PV ;
Christ, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :382-395
[10]   HUMAN GROWTH-HORMONE AND HUMAN AGING [J].
CORPAS, E ;
HARMAN, SM ;
BLACKMAN, MR .
ENDOCRINE REVIEWS, 1993, 14 (01) :20-39